Clinical end point acceptance limit [Study As­sess­ment]

posted by PKS – India, 2019-04-05 10:45 (1845 d 03:19 ago) – Posting: # 20125
Views: 3,793

Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)

Edit: Category changed; see also this post #1. Please follow the Forum’s Policy. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,990 posts in 4,826 threads, 1,665 registered users;
57 visitors (1 registered, 56 guests [including 4 identified bots]).
Forum time: 14:05 CEST (Europe/Vienna)

If you don’t like something change it;
if you can’t change it, change the way you think about it.    Mary Engelbreit

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5